Results 31 to 40 of about 2,582 (154)

Late metastatic presentation is associated with improved survival and delayed wide‐spread progression after ablative stereotactic body radiotherapy for oligometastasis

open access: yesCancer Medicine, 2021
Background Stereotactic body radiotherapy (SBRT) is increasingly used to treat oligometastatic disease (OMD), but the effect of metastasis timing on patient outcomes remains uncertain.
Xuguang Chen   +11 more
doaj   +1 more source

Oligometastasis to testis in prostate cancer: Role of gallium-68 prostate-specific membrane antigen positron-emission tomography computed tomography

open access: yesWorld Journal of Nuclear Medicine, 2021
Accurate staging and restaging with early detection of recurrent site is the key for planning treatment in patients of prostate cancer. Recently, gallium-68 prostate-specific membrane antigen positron-emission tomography computed tomography (68Ga-PSMA ...
Manoj Gupta   +3 more
doaj   +1 more source

Genomic features and its potential implication in bone oligometastatic NSCLC

open access: yesBMC Pulmonary Medicine, 2023
Objectives Emerging evidence have demonstrated that oligometastatic non-small cell lung cancer (NSCLC) can achieve clinical benefit from local consolidative therapy.
Rongxin Liao   +6 more
doaj   +1 more source

Stereotactic Body Radiation Therapy for the Treatment of Locally Recurrent and Oligoprogressive Non-Small Cell Lung Cancer: A Single Institution Experience

open access: yesFrontiers in Oncology, 2022
ObjectivesTo investigate the efficacy and safety of lung stereotactic body radiation therapy (SBRT) for non-small cell lung cancer (NSCLC) including oligorecurrent and oligoprogressive disease.MethodsSingle-institution retrospective analysis of 60 NSCLC ...
Leah M. Katz   +10 more
doaj   +1 more source

Overall survival after recurrence in stage I–III colorectal cancer patients in accordance with the recurrence organ site and pattern

open access: yesAnnals of Gastroenterological Surgery, 2021
Aim This study aimed to investigate the prognosis after recurrence in patients with stage I–III colon cancer (CC) and rectal cancer (RC). Methods Cancer recurred in 116 (15.2%) out of 763 patients with stage I–III colorectal cancer. The overall survival (
Hiroshi Sawayama   +8 more
doaj   +1 more source

A case of discordant histology and expression of programmed death ligand 1 between primary tumor and brain metastases in adenosquamous carcinoma of the lung

open access: yesThoracic Cancer, 2023
A patient presented with vomiting and gait disturbance. Investigation revealed a single cerebellar tumor and another tumor in the upper lobe of the left lung.
Hironori Takagi   +6 more
doaj   +1 more source

Successful Multidisciplinary Treatment with Laparoscopic Hepatectomy and Adjuvant Therapy for Metachronous Solitary Hepatic Metastasis after Excision of a Primary Anorectal Malignant Melanoma: A Case Report

open access: yesCurrent Oncology, 2023
Anorectal malignant melanoma (ARMM) is extremely rare and generally lethal, irrespective of the treatment administered. The disease is often diagnosed late, metastases being present in approximately two-thirds of patients at the time of initial diagnosis.
Ryotaro Shimazaki   +10 more
doaj   +1 more source

A Case of Brachial Lymph Node Recurrences after the Resection of Locally Advanced Breast Cancer

open access: yesCase Reports in Oncology, 2022
We present a case of two recurrences in the brachial lymph nodes after initial resection, which was performed for radical cure. A 66-year-old woman was diagnosed with left breast cancer T4bN3cM0 Stage IIIC and an immunohistochemistry assay showed ...
Kayono Onishi   +5 more
doaj   +1 more source

An adrenal incidentaloma caused by synchronous and isolated metastasis

open access: yesClinical Case Reports, 2021
We report a patient with adrenal incidentaloma due to synchronous and isolated metastasis from lung cancer, which is a relatively rare condition. Close checkups for incidentaloma in oncologic patients are mandatory, leading to successful operation.
Koichiro Yamamoto   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy